Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007

Background Human Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in HIV-1 infected patients during pre (1995-1996), early (1997-1999), and late Highly Active Antiretroviral Therapy (HAART) (2000-2007) periods. Methods...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	BMC pulmonary medicine Ročník 11; číslo 1; s. 26
Hlavní autori:	Taarnhøj, Gry A, Engsig, Frederik N, Ravn, Pernille, Johansen, Isik S, Larsen, Carsten S, Røge, Birgit, Andersen, Aase B, Obel, Niels
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London BioMed Central 23.05.2011 BMC
Predmet:	Adult Africa - ethnology AIDS-Related Opportunistic Infections - epidemiology AIDS-Related Opportunistic Infections - mortality Antiretroviral Therapy, Highly Active Asia - ethnology CD4 Lymphocyte Count Cohort Studies Critical Care Medicine Denmark - epidemiology Female HIV Infections - complications HIV Infections - drug therapy Humans Incidence Intensive Internal Medicine Kaplan-Meier Estimate Male Medicine Medicine & Public Health Middle Aged Pneumology/Respiratory System Regression Analysis Research Article Retrospective Studies Risk Factors Tuberculosis, Pulmonary - epidemiology Tuberculosis, Pulmonary - mortality Denmark Asia Africa Human Immunodeficiency Virus Transmission Injection Drug User Human Immunodeficiency Virus Infection Human Immunodeficiency Virus Patient Human Immunodeficiency Virus
ISSN:	1471-2466, 1471-2466
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Background Human Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in HIV-1 infected patients during pre (1995-1996), early (1997-1999), and late Highly Active Antiretroviral Therapy (HAART) (2000-2007) periods. Methods We included patients from a population-based, multicenter, nationwide cohort. We calculated incidence rates (IRs) and mortality rates (MRs). Cox's regression analysis was used to estimate risk factors for TB infection with HAART initiation included as time updated variable. Kaplan-Meier was used to estimate mortality after TB. Results Among 2,668 patients identified, 120 patients developed TB during the follow-up period. The overall IR was 8.2 cases of TB/1,000 person-years of follow-up (PYR). IRs decreased during the pre-, early and late-HAART periods (37.1/1000 PYR, 12.9/1000 PYR and 6.5/1000 PYR respectively). African and Asian origin, low CD4 cell count and heterosexual and injection drug user route of HIV transmission were risk factors for TB and start of HAART reduced the risk substantially. The overall MR in TB patients was 34.4 deaths per 1,000 PYR (95% Confidence Interval: 22.0-54.0) and was highest in the first two years after the diagnosis of TB. Conclusions Incidence of TB still associated with conventional risk factors as country of birth, low CD4 count and route of HIV infection while HAART reduces the risk substantially. The mortality in this patient population is high in the first two years after TB diagnosis.
AbstractList	Human Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in HIV-1 infected patients during pre (1995-1996), early (1997-1999), and late Highly Active Antiretroviral Therapy (HAART) (2000-2007) periods.BACKGROUNDHuman Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in HIV-1 infected patients during pre (1995-1996), early (1997-1999), and late Highly Active Antiretroviral Therapy (HAART) (2000-2007) periods.We included patients from a population-based, multicenter, nationwide cohort. We calculated incidence rates (IRs) and mortality rates (MRs). Cox's regression analysis was used to estimate risk factors for TB infection with HAART initiation included as time updated variable. Kaplan-Meier was used to estimate mortality after TB.METHODSWe included patients from a population-based, multicenter, nationwide cohort. We calculated incidence rates (IRs) and mortality rates (MRs). Cox's regression analysis was used to estimate risk factors for TB infection with HAART initiation included as time updated variable. Kaplan-Meier was used to estimate mortality after TB.Among 2,668 patients identified, 120 patients developed TB during the follow-up period. The overall IR was 8.2 cases of TB/1,000 person-years of follow-up (PYR). IRs decreased during the pre-, early and late-HAART periods (37.1/1000 PYR, 12.9/1000 PYR and 6.5/1000 PYR respectively). African and Asian origin, low CD4 cell count and heterosexual and injection drug user route of HIV transmission were risk factors for TB and start of HAART reduced the risk substantially. The overall MR in TB patients was 34.4 deaths per 1,000 PYR (95% Confidence Interval: 22.0-54.0) and was highest in the first two years after the diagnosis of TB.RESULTSAmong 2,668 patients identified, 120 patients developed TB during the follow-up period. The overall IR was 8.2 cases of TB/1,000 person-years of follow-up (PYR). IRs decreased during the pre-, early and late-HAART periods (37.1/1000 PYR, 12.9/1000 PYR and 6.5/1000 PYR respectively). African and Asian origin, low CD4 cell count and heterosexual and injection drug user route of HIV transmission were risk factors for TB and start of HAART reduced the risk substantially. The overall MR in TB patients was 34.4 deaths per 1,000 PYR (95% Confidence Interval: 22.0-54.0) and was highest in the first two years after the diagnosis of TB.Incidence of TB still associated with conventional risk factors as country of birth, low CD4 count and route of HIV infection while HAART reduces the risk substantially. The mortality in this patient population is high in the first two years after TB diagnosis.CONCLUSIONSIncidence of TB still associated with conventional risk factors as country of birth, low CD4 count and route of HIV infection while HAART reduces the risk substantially. The mortality in this patient population is high in the first two years after TB diagnosis. Human Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in HIV-1 infected patients during pre (1995-1996), early (1997-1999), and late Highly Active Antiretroviral Therapy (HAART) (2000-2007) periods. We included patients from a population-based, multicenter, nationwide cohort. We calculated incidence rates (IRs) and mortality rates (MRs). Cox's regression analysis was used to estimate risk factors for TB infection with HAART initiation included as time updated variable. Kaplan-Meier was used to estimate mortality after TB. Among 2,668 patients identified, 120 patients developed TB during the follow-up period. The overall IR was 8.2 cases of TB/1,000 person-years of follow-up (PYR). IRs decreased during the pre-, early and late-HAART periods (37.1/1000 PYR, 12.9/1000 PYR and 6.5/1000 PYR respectively). African and Asian origin, low CD4 cell count and heterosexual and injection drug user route of HIV transmission were risk factors for TB and start of HAART reduced the risk substantially. The overall MR in TB patients was 34.4 deaths per 1,000 PYR (95% Confidence Interval: 22.0-54.0) and was highest in the first two years after the diagnosis of TB. Incidence of TB still associated with conventional risk factors as country of birth, low CD4 count and route of HIV infection while HAART reduces the risk substantially. The mortality in this patient population is high in the first two years after TB diagnosis. Abstract Background Human Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in HIV-1 infected patients during pre (1995-1996), early (1997-1999), and late Highly Active Antiretroviral Therapy (HAART) (2000-2007) periods. Methods We included patients from a population-based, multicenter, nationwide cohort. We calculated incidence rates (IRs) and mortality rates (MRs). Cox's regression analysis was used to estimate risk factors for TB infection with HAART initiation included as time updated variable. Kaplan-Meier was used to estimate mortality after TB. Results Among 2,668 patients identified, 120 patients developed TB during the follow-up period. The overall IR was 8.2 cases of TB/1,000 person-years of follow-up (PYR). IRs decreased during the pre-, early and late-HAART periods (37.1/1000 PYR, 12.9/1000 PYR and 6.5/1000 PYR respectively). African and Asian origin, low CD4 cell count and heterosexual and injection drug user route of HIV transmission were risk factors for TB and start of HAART reduced the risk substantially. The overall MR in TB patients was 34.4 deaths per 1,000 PYR (95% Confidence Interval: 22.0-54.0) and was highest in the first two years after the diagnosis of TB. Conclusions Incidence of TB still associated with conventional risk factors as country of birth, low CD4 count and route of HIV infection while HAART reduces the risk substantially. The mortality in this patient population is high in the first two years after TB diagnosis. Background Human Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in HIV-1 infected patients during pre (1995-1996), early (1997-1999), and late Highly Active Antiretroviral Therapy (HAART) (2000-2007) periods. Methods We included patients from a population-based, multicenter, nationwide cohort. We calculated incidence rates (IRs) and mortality rates (MRs). Cox's regression analysis was used to estimate risk factors for TB infection with HAART initiation included as time updated variable. Kaplan-Meier was used to estimate mortality after TB. Results Among 2,668 patients identified, 120 patients developed TB during the follow-up period. The overall IR was 8.2 cases of TB/1,000 person-years of follow-up (PYR). IRs decreased during the pre-, early and late-HAART periods (37.1/1000 PYR, 12.9/1000 PYR and 6.5/1000 PYR respectively). African and Asian origin, low CD4 cell count and heterosexual and injection drug user route of HIV transmission were risk factors for TB and start of HAART reduced the risk substantially. The overall MR in TB patients was 34.4 deaths per 1,000 PYR (95% Confidence Interval: 22.0-54.0) and was highest in the first two years after the diagnosis of TB. Conclusions Incidence of TB still associated with conventional risk factors as country of birth, low CD4 count and route of HIV infection while HAART reduces the risk substantially. The mortality in this patient population is high in the first two years after TB diagnosis.
ArticleNumber	26
Author	Larsen, Carsten S Andersen, Aase B Taarnhøj, Gry A Ravn, Pernille Røge, Birgit Obel, Niels Engsig, Frederik N Johansen, Isik S
AuthorAffiliation	1 Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark 5 Department of Infectious Diseases, Odense University Hospital, Sønderboulevard 29, 5000 Odense, Denmark 2 Department of Infectious Diseases, Copenhagen University Hospital, Herlev Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark 3 Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre Hospital, Kettegård Allé 30, 2650 Hvidovre Denmark 4 Department of Infectious Diseases, Aarhus University Hospital, Skejby Sygehus, Brendstrupgårdsvej 100, 8200 Århus N, Denmark
AuthorAffiliation_xml	– name: 1 Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark – name: 3 Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre Hospital, Kettegård Allé 30, 2650 Hvidovre Denmark – name: 5 Department of Infectious Diseases, Odense University Hospital, Sønderboulevard 29, 5000 Odense, Denmark – name: 4 Department of Infectious Diseases, Aarhus University Hospital, Skejby Sygehus, Brendstrupgårdsvej 100, 8200 Århus N, Denmark – name: 2 Department of Infectious Diseases, Copenhagen University Hospital, Herlev Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark
Author_xml	– sequence: 1 givenname: Gry A surname: Taarnhøj fullname: Taarnhøj, Gry A email: gry_assam@hotmail.com organization: Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet – sequence: 2 givenname: Frederik N surname: Engsig fullname: Engsig, Frederik N organization: Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet – sequence: 3 givenname: Pernille surname: Ravn fullname: Ravn, Pernille organization: Department of Infectious Diseases, Copenhagen University Hospital, Herlev Hospital – sequence: 4 givenname: Isik S surname: Johansen fullname: Johansen, Isik S organization: Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre Hospital – sequence: 5 givenname: Carsten S surname: Larsen fullname: Larsen, Carsten S organization: Department of Infectious Diseases, Aarhus University Hospital – sequence: 6 givenname: Birgit surname: Røge fullname: Røge, Birgit organization: Department of Infectious Diseases, Odense University Hospital – sequence: 7 givenname: Aase B surname: Andersen fullname: Andersen, Aase B organization: Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet – sequence: 8 givenname: Niels surname: Obel fullname: Obel, Niels organization: Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/21605366$$D View this record in MEDLINE/PubMed
BookMark	eNp9kTtvHCEUhVHkKH4kdbqILk0m5j0zTaTIeXglS2lst-gOMGs2s7ABxpL_fVivs7ItORVwOec7oHOMDkIMDqH3lHymtFOnVLS0YUKphtZVvUJH-8nBo_0hOs55RQhtO8nfoENGFZFcqSN0vQjGWxeM-4STz7_xCKbElDEEi9cxFZh8ucNxxGUeXDLzFLPP2Af8DYLPN_h8cY03ULwLJWPa97JhhLRv0esRpuzePawn6OrH98uz8-bi18_F2deLxoi-Lw2VBKAfnGlBKMP4MDhwxDLZDh2n1plOjlKBFdQBkXakwHsHHZGMc6Is8BO02HFthJXeJL-GdKcjeH0_iGmpIRVvJqe7jkluYGjFwAUoA6OzvRWjMUqYQdnK-rJjbeZh7aypP0owPYE-vQn-Ri_jreaUyp6pCvj4AEjxz-xy0WufjZsmCC7OWXctE7ztCKvKD4-j9hn_eqmC053ApJhzcuNeQoneNq-33eptt_Wo78PlM4fxpfYSt2_10398ZOfLNSEsXdKrOKdQS3vR8hc43sCX
CitedBy_id	crossref_primary_10_1080_17843286_2018_1494669 crossref_primary_10_1080_23744235_2018_1486511 crossref_primary_10_1016_j_cmi_2021_07_036 crossref_primary_10_1097_MD_0000000000010486 crossref_primary_10_1136_thoraxjnl_2014_206452 crossref_primary_10_1183_09031936_00170913 crossref_primary_10_4103_1817_1737_160838 crossref_primary_10_1093_cid_civ326 crossref_primary_10_1016_j_ijmm_2016_05_017 crossref_primary_10_1016_j_jmii_2013_05_001 crossref_primary_10_1097_QAD_0000000000001635 crossref_primary_10_1111_dar_13233 crossref_primary_10_1371_journal_pone_0079691 crossref_primary_10_1371_journal_pone_0111209 crossref_primary_10_3109_00365548_2012_684220 crossref_primary_10_1097_QAD_0000000000001252 crossref_primary_10_1128_JCM_01916_13 crossref_primary_10_1097_COH_0b013e328354bd44 crossref_primary_10_1089_aid_2012_0239 crossref_primary_10_1590_1413_812320172211_26352015
Cites_doi	10.7326/0003-4819-146-2-200701160-00003 10.7326/0003-4819-126-2-199701150-00005 10.1086/510080 10.1093/qjmed/90.7.449 10.1186/1471-2334-9-46 10.1080/00365540510031692 10.1164/rccm.200410-1342OC 10.1086/595985 10.1590/S0037-86822008000600001 10.1136/jech.2008.077560 10.1097/01.aids.0000194808.20035.c1 10.1164/ajrccm.162.3.9908018 10.1183/09031936.96.09020279 10.1086/498315 10.1097/QAD.0b013e328327964f
ContentType	Journal Article
Copyright	Taarnhøj et al; licensee BioMed Central Ltd. 2011 Copyright ©2011 Taarnhøj et al; licensee BioMed Central Ltd. 2011 Taarnhøj et al; licensee BioMed Central Ltd.
Copyright_xml	– notice: Taarnhøj et al; licensee BioMed Central Ltd. 2011 – notice: Copyright ©2011 Taarnhøj et al; licensee BioMed Central Ltd. 2011 Taarnhøj et al; licensee BioMed Central Ltd.
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA
DOI	10.1186/1471-2466-11-26
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1471-2466
EndPage	26
ExternalDocumentID	oai_doaj_org_article_88253cab74b34a6cafed9d4fcc64cb6d PMC3115926 21605366 10_1186_1471_2466_11_26
Genre	Multicenter Study Journal Article Comparative Study
GeographicLocations	Denmark Asia Africa
GeographicLocations_xml	– name: Denmark – name: Africa – name: Asia
GroupedDBID	--- 0R~ 23N 2VQ 2WC 4.4 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C1A C6C CCPQU CS3 DIK DU5 E3Z EBLON EBS EJD EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR IPNFZ ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RIG RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION -A0 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM 7X8 5PM
ID	FETCH-LOGICAL-c499t-150aa9bec7a46c23bbeae0d257b831dec85f56ad41ea05df1a39ea80523306da3
IEDL.DBID	RSV
ISICitedReferencesCount	26
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000208592800026&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1471-2466
IngestDate	Fri Oct 03 12:52:54 EDT 2025 Tue Nov 04 01:47:18 EST 2025 Sun Nov 09 14:43:08 EST 2025 Thu Jan 02 22:27:26 EST 2025 Tue Nov 18 22:25:27 EST 2025 Sat Nov 29 03:57:23 EST 2025 Sat Sep 06 07:21:57 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Human Immunodeficiency Virus Transmission Injection Drug User Human Immunodeficiency Virus Infection Human Immunodeficiency Virus Patient Human Immunodeficiency Virus
Language	English
License	http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c499t-150aa9bec7a46c23bbeae0d257b831dec85f56ad41ea05df1a39ea80523306da3
Notes	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23
OpenAccessLink	https://link.springer.com/10.1186/1471-2466-11-26
PMID	21605366
PQID	872437802
PQPubID	23479
PageCount	1
ParticipantIDs	doaj_primary_oai_doaj_org_article_88253cab74b34a6cafed9d4fcc64cb6d pubmedcentral_primary_oai_pubmedcentral_nih_gov_3115926 proquest_miscellaneous_872437802 pubmed_primary_21605366 crossref_primary_10_1186_1471_2466_11_26 crossref_citationtrail_10_1186_1471_2466_11_26 springer_journals_10_1186_1471_2466_11_26
PublicationCentury	2000
PublicationDate	20110523
PublicationDateYYYYMMDD	2011-05-23
PublicationDate_xml	– month: 5 year: 2011 text: 20110523 day: 23
PublicationDecade	2010
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	BMC pulmonary medicine
PublicationTitleAbbrev	BMC Pulm Med
PublicationTitleAlternate	BMC Pulm Med
PublicationYear	2011
Publisher	BioMed Central BMC
Publisher_xml	– name: BioMed Central – name: BMC
References	Lohse, Hansen, Jensen-Fangel, Kronborg, Kvinesdal, Pedersen, Larsen, Møller, Willumsen, Obel (CR10) 2005; 37 Elzi, Schlegel, Weber, Hirschel, Cavassini, Schmid, Bernasconi, Rickenbach, Furrer (CR4) 2007; 44 Kirk, Gatell, Mocroft, Pedersen, Proenca, Brettle, Barton, Sudre, Phillips (CR5) 2000; 162 Lawn, Badri, Wood (CR17) 2005; 19 Juel, Helweg-Larsen (CR12) 1999; 46 Wu, Chang, Chang, Yang, Liao (CR20) 1997; 30 Obel, Engsig, Rasmussen, Larsen, Omland, Sørensen (CR11) 2008 Maartens, Wood, O'Keefe, Byrne (CR19) 1997; 90 Millet, Orcau, de Olalla, Casals, Rius, Caylà (CR8) 2009; 63 CR9 Zhou, Elliott, Li, Lim, Kiertiburanakul, Kumarasamy, Merati, Pujari, Chen, Phanuphak, Vonthanak, Sirisanthana, Sungkanuparph, Lee, Kamarulzaman, Oka, Zhang, Tau, Ditangco (CR7) 2009; 9 CR21 Markowitz, Hansen, Hopewell, Glassroth, Kvale, Mangura, Wilcosky, Wallace, Rosen, Reichman (CR16) 2007; 126 Moreno, Jarrin, Iribarren, Perez-Elias, Viciana, Parra, Gomez-Sirvent, Lopez-Aldeguer, Gutierrez, Blanco, Vidal, Leal, Rodriguez Arenas, del Amo, Coris (CR2) 2008; 12 Seyler, Toure, Messou, Bonard, Gabillard, Anglaret (CR13) 2005; 172 Manabe, Breen, Perti, Girardi, Sterling (CR14) 2009; 199 Sudre, Hirschel, Toscani, Ledergerber, Rieder (CR6) 1996; 9 Lannoy, Cortez-Escalante, Evangelista, Romero (CR18) 2008; 41 Lohse, Hansen, Pedersen, Kronborg, Gerstoft, Sørensen, Vaeth, Obel (CR1) 2007; 146 Girardi, Sabin, d'Arminio Monforte, Hogg, Phillips, Gill, Dabis, Reiss, Kirk, Bernasconi, Grabar, Justice, Staszewski, Fätkenheuer, Sterne (CR15) 2005; 41 Rieder (CR3) 2007; 44 L Elzi (257_CR4) 2007; 44 257_CR21 P Sudre (257_CR6) 1996; 9 YC Manabe (257_CR14) 2009; 199 257_CR9 N Markowitz (257_CR16) 2007; 126 SD Lawn (257_CR17) 2005; 19 S Moreno (257_CR2) 2008; 12 YL Wu (257_CR20) 1997; 30 N Lohse (257_CR10) 2005; 37 JP Millet (257_CR8) 2009; 63 LH Lannoy (257_CR18) 2008; 41 O Kirk (257_CR5) 2000; 162 K Juel (257_CR12) 1999; 46 HL Rieder (257_CR3) 2007; 44 N Obel (257_CR11) 2008 C Seyler (257_CR13) 2005; 172 E Girardi (257_CR15) 2005; 41 G Maartens (257_CR19) 1997; 90 J Zhou (257_CR7) 2009; 9 N Lohse (257_CR1) 2007; 146 10988097 - Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):865-72 10514943 - Dan Med Bull. 1999 Sep;46(4):354-7 19142430 - Rev Soc Bras Med Trop. 2008 Nov-Dec;41(6):549-55 9005746 - Ann Intern Med. 1997 Jan 15;126(2):123-32 8777964 - Eur Respir J. 1996 Feb;9(2):279-83 19383122 - BMC Infect Dis. 2009;9:46 16288403 - Clin Infect Dis. 2005 Dec 15;41(12):1772-82 17143823 - Clin Infect Dis. 2007 Jan 1;44(1):94-102 9302428 - QJM. 1997 Jul;90(7):449-54 16051569 - Scand J Infect Dis. 2005;37(5):338-43 15805184 - Am J Respir Crit Care Med. 2005 Jul 1;172(1):123-7 16284460 - AIDS. 2005 Dec 2;19(18):2109-16 18799495 - Int J Epidemiol. 2009 Oct;38(5):1202-6 17143824 - Clin Infect Dis. 2007 Jan 1;44(1):103-4 19017448 - Int J Tuberc Lung Dis. 2008 Dec;12(12):1393-400 17227932 - Ann Intern Med. 2007 Jan 16;146(2):87-95 19090776 - J Infect Dis. 2009 Feb 1;199(3):437-44 10592814 - Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1997 May;30(2):84-95 19525621 - AIDS. 2009 Mar 13;23(5):631-6 19179367 - J Epidemiol Community Health. 2009 Oct;63(10):799-804
References_xml	– ident: CR21 – volume: 146 start-page: 87 issue: 2 year: 2007 end-page: 95 ident: CR1 article-title: Survival of persons with and without HIV infection in Denmark 1995-2005 publication-title: Ann Intern Med doi: 10.7326/0003-4819-146-2-200701160-00003 – year: 2008 ident: CR11 article-title: Cohort Profile: The Danish HIV Cohort Study publication-title: Int J Epidemiol – volume: 126 start-page: 123 issue: 2 year: 2007 end-page: 132 ident: CR16 article-title: Incidence of Tuberculosis in the United States among HIV-infected Persons publication-title: Ann Intern Med doi: 10.7326/0003-4819-126-2-199701150-00005 – volume: 12 start-page: 1393 issue: 12 year: 2008 end-page: 1400 ident: CR2 article-title: Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status publication-title: Int J Tuberc Lung Dis – volume: 44 start-page: 94 year: 2007 end-page: 102 ident: CR4 article-title: Swiss HIV Cohort Study. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission publication-title: Clin Infect Dis doi: 10.1086/510080 – volume: 90 start-page: 449 issue: 7 year: 1997 end-page: 54 ident: CR19 article-title: Independent epidemics of heterosexual and homosexual HIV infection in South Africa - survival differences publication-title: QJM doi: 10.1093/qjmed/90.7.449 – volume: 9 start-page: 46 year: 2009 ident: CR7 article-title: Risk and prognostic significance of tuberculosis in patient from The TREAT Asia HIV Observational Database publication-title: BMC Infectious Diseases doi: 10.1186/1471-2334-9-46 – volume: 37 start-page: 338 issue: 5 year: 2005 end-page: 43 ident: CR10 article-title: Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study publication-title: Scand J Infect Dis doi: 10.1080/00365540510031692 – volume: 172 start-page: 123 year: 2005 end-page: 127 ident: CR13 article-title: Risk factors for Active Tuberculosis after Antiretroviral Treatment Initiation in Abidjan publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200410-1342OC – volume: 30 start-page: 84 issue: 2 year: 1997 end-page: 95 ident: CR20 article-title: Clinical experience of HIV/AIDS in a municipal hospital in Taiwan publication-title: Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi – ident: CR9 – volume: 46 start-page: 354 year: 1999 end-page: 357 ident: CR12 article-title: The Danish registers of causes of death publication-title: Dan Med Bull – volume: 199 start-page: 437 issue: 3 year: 2009 end-page: 444 ident: CR14 article-title: Unmasked Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Disease: A Disease Spectrum after Initiation of Antiretroviral Therapy publication-title: JID doi: 10.1086/595985 – volume: 41 start-page: 549 issue: 6 year: 2008 end-page: 555 ident: CR18 article-title: Tuberculosis incidence and risk factors among patients living with HIV/AIDS in public health service institutions in Brasilia, Federal District publication-title: Rev Soc Bras Med Trop doi: 10.1590/S0037-86822008000600001 – volume: 63 start-page: 799 issue: 10 year: 2009 end-page: 804 ident: CR8 article-title: Tuberculosis recurrence and its associated risk factors among successfully treated patients publication-title: J Epidemiol Community Health doi: 10.1136/jech.2008.077560 – volume: 19 start-page: 2109 year: 2005 end-page: 2116 ident: CR17 article-title: Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort publication-title: AIDS doi: 10.1097/01.aids.0000194808.20035.c1 – volume: 44 start-page: 103 year: 2007 end-page: 104 ident: CR3 article-title: Preventing Latent Tuberculosis among HIV Infected Patients: Efficacious and Effective, yet Inefficient? publication-title: Editorial Commentary: Clin Infect Dis – volume: 162 start-page: 865 year: 2000 end-page: 872 ident: CR5 article-title: Infections with and among HIV-infected Patients after the Introduction of Highly Active Antiretroviral Therapy publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.162.3.9908018 – volume: 9 start-page: 279 year: 1996 end-page: 283 ident: CR6 article-title: Risk factors for Tuberculosis among HIV-infected patients in Switzerland publication-title: Eur Respir J doi: 10.1183/09031936.96.09020279 – volume: 41 start-page: 1772 issue: 12 year: 2005 end-page: 82 ident: CR15 article-title: Incidence of Tuberculosis among HIV-infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America publication-title: CID doi: 10.1086/498315 – volume: 41 start-page: 549 issue: 6 year: 2008 ident: 257_CR18 publication-title: Rev Soc Bras Med Trop doi: 10.1590/S0037-86822008000600001 – volume: 46 start-page: 354 year: 1999 ident: 257_CR12 publication-title: Dan Med Bull – volume: 146 start-page: 87 issue: 2 year: 2007 ident: 257_CR1 publication-title: Ann Intern Med doi: 10.7326/0003-4819-146-2-200701160-00003 – volume: 126 start-page: 123 issue: 2 year: 2007 ident: 257_CR16 publication-title: Ann Intern Med doi: 10.7326/0003-4819-126-2-199701150-00005 – volume: 30 start-page: 84 issue: 2 year: 1997 ident: 257_CR20 publication-title: Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi – volume: 172 start-page: 123 year: 2005 ident: 257_CR13 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200410-1342OC – volume: 44 start-page: 103 year: 2007 ident: 257_CR3 publication-title: Editorial Commentary: Clin Infect Dis – volume: 9 start-page: 279 year: 1996 ident: 257_CR6 publication-title: Eur Respir J doi: 10.1183/09031936.96.09020279 – volume: 90 start-page: 449 issue: 7 year: 1997 ident: 257_CR19 publication-title: QJM doi: 10.1093/qjmed/90.7.449 – volume: 12 start-page: 1393 issue: 12 year: 2008 ident: 257_CR2 publication-title: Int J Tuberc Lung Dis – volume: 41 start-page: 1772 issue: 12 year: 2005 ident: 257_CR15 publication-title: CID doi: 10.1086/498315 – volume: 199 start-page: 437 issue: 3 year: 2009 ident: 257_CR14 publication-title: JID doi: 10.1086/595985 – ident: 257_CR21 doi: 10.1097/QAD.0b013e328327964f – volume: 44 start-page: 94 year: 2007 ident: 257_CR4 publication-title: Clin Infect Dis doi: 10.1086/510080 – volume: 162 start-page: 865 year: 2000 ident: 257_CR5 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.162.3.9908018 – volume: 9 start-page: 46 year: 2009 ident: 257_CR7 publication-title: BMC Infectious Diseases doi: 10.1186/1471-2334-9-46 – volume: 63 start-page: 799 issue: 10 year: 2009 ident: 257_CR8 publication-title: J Epidemiol Community Health doi: 10.1136/jech.2008.077560 – volume-title: Int J Epidemiol year: 2008 ident: 257_CR11 – ident: 257_CR9 – volume: 37 start-page: 338 issue: 5 year: 2005 ident: 257_CR10 publication-title: Scand J Infect Dis doi: 10.1080/00365540510031692 – volume: 19 start-page: 2109 year: 2005 ident: 257_CR17 publication-title: AIDS doi: 10.1097/01.aids.0000194808.20035.c1 – reference: 10514943 - Dan Med Bull. 1999 Sep;46(4):354-7 – reference: 8777964 - Eur Respir J. 1996 Feb;9(2):279-83 – reference: 10988097 - Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):865-72 – reference: 18799495 - Int J Epidemiol. 2009 Oct;38(5):1202-6 – reference: 16284460 - AIDS. 2005 Dec 2;19(18):2109-16 – reference: 16288403 - Clin Infect Dis. 2005 Dec 15;41(12):1772-82 – reference: 17227932 - Ann Intern Med. 2007 Jan 16;146(2):87-95 – reference: 9302428 - QJM. 1997 Jul;90(7):449-54 – reference: 19383122 - BMC Infect Dis. 2009;9:46 – reference: 10592814 - Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1997 May;30(2):84-95 – reference: 9005746 - Ann Intern Med. 1997 Jan 15;126(2):123-32 – reference: 17143824 - Clin Infect Dis. 2007 Jan 1;44(1):103-4 – reference: 17143823 - Clin Infect Dis. 2007 Jan 1;44(1):94-102 – reference: 15805184 - Am J Respir Crit Care Med. 2005 Jul 1;172(1):123-7 – reference: 19179367 - J Epidemiol Community Health. 2009 Oct;63(10):799-804 – reference: 19142430 - Rev Soc Bras Med Trop. 2008 Nov-Dec;41(6):549-55 – reference: 19525621 - AIDS. 2009 Mar 13;23(5):631-6 – reference: 19017448 - Int J Tuberc Lung Dis. 2008 Dec;12(12):1393-400 – reference: 19090776 - J Infect Dis. 2009 Feb 1;199(3):437-44 – reference: 16051569 - Scand J Infect Dis. 2005;37(5):338-43
SSID	ssj0017853
Score	2.0364044
Snippet	Background Human Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in HIV-1... Human Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in HIV-1 infected... Abstract Background Human Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in...
SourceID	doaj pubmedcentral proquest pubmed crossref springer
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	26
SubjectTerms	Adult Africa - ethnology AIDS-Related Opportunistic Infections - epidemiology AIDS-Related Opportunistic Infections - mortality Antiretroviral Therapy, Highly Active Asia - ethnology CD4 Lymphocyte Count Cohort Studies Critical Care Medicine Denmark - epidemiology Female HIV Infections - complications HIV Infections - drug therapy Humans Incidence Intensive Internal Medicine Kaplan-Meier Estimate Male Medicine Medicine & Public Health Middle Aged Pneumology/Respiratory System Regression Analysis Research Article Retrospective Studies Risk Factors Tuberculosis, Pulmonary - epidemiology Tuberculosis, Pulmonary - mortality
SummonAdditionalLinks	– databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQhRAXxJvlJR84gETo-hHbOQKiKgcqDlD1Zo0fUVdqs2izy-9nxvGuukDFhWMcR7Fnxp5v_PiGsVcIUgNY1zVdb-cNeqjUOJkp3Qv6ZvRwSgkoySbsyYk7O-u-Xkn1RWfCJnrgSXCHiABbFSFYHZQGE6HPqUu6j9HoGEyi2RdRzzaYqvsH1hX-SYFTbyO1MZXURzhzuCujG2XEqXDFHxXa_r9hzT-PTP62b1rc0dFddqfiSP5-av89diMP99mtL3Wn_AE7xYE_5Qt9y-n4OK-JdTgMiV8WzI34my97vt6EvIqbi-W4GPli4HTpfDznx59PeSVdHXm5YU3rjQ_Z96NP3z4eNzWHQhMxllk3iPcAOlSUBW2iVCFkyPOEAzU4VEyOru1bA0mLDPM29QJUl4HyHCgMJhKoR-xgWA75CePGyADCii6hJnIUYLSRSfZBWwRhXTtj77aS9LESjFOeiwtfAg1nPInek-jx0UszY693H_yYuDWur_qBVLOrRqTYpQBNxVdT8f8ylRnjW8V6HES0MwJDXm5G7yzxMrq5nLHHk553f5ICAz5lsAV2zwL2mrL_ZlicF55uIjLqqO1vtrbi6wQxXtfPp_-jn8_Y7WnlGy1DPWcH69Umv2A348_1Yly9LAPlF0gmFCs priority: 102 providerName: Directory of Open Access Journals
Title	Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007
URI	https://link.springer.com/article/10.1186/1471-2466-11-26 https://www.ncbi.nlm.nih.gov/pubmed/21605366 https://www.proquest.com/docview/872437802 https://pubmed.ncbi.nlm.nih.gov/PMC3115926 https://doaj.org/article/88253cab74b34a6cafed9d4fcc64cb6d
Volume	11
WOSCitedRecordID	wos000208592800026&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: Directory of Open Access Journals customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: Springer Journals customDbUrl: eissn: 1471-2466 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017853 issn: 1471-2466 databaseCode: RSV dateStart: 20011201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB7tAyEuvB_lUfnAASQCje3YzpFFu9o9bFUtUJWT5VfYSkuCmpbfz9hJKhV2D3CJ5MRRJvaMZ8bj-QbgNRqp1khVZmUlJxlqKJ8pGmK5F9TNqOEYy00qNiGnU7VYlLM9yIdcmHTafQhJppU6ibUSH3JcRjPKhYiZYFTswyHqOhVl8eLzfBs4kKh-egSfa17aUT4Jo_86w_Lv85F_BEmT7jm59x9U34e7vaFJPnac8QD2Qv0Qbp_3ofRHMMeVoSso-o7E8-Wkr7xDTO3Jj2SUo4FOmoqsNzas3OaqaZctWdYkZqW3l-T0bE56VNaWpBTsuCH5GL6eHH_5dJr1RRYyh87OOkOD0JgSZ1IaLhxl1gYTJh4l2SqcueBUURXCeJ4HMyl8lRtWBhMLITD0NrxhT-CgburwDIgQ1Jpc5qW3jAeXG8EF9bSyXKKVVhYjeD-MvnY9AnkshHGlkyeihI6jpeNoYVNTMYI32xd-duAbN3c9itO57RZRs9ONZvVd90Ko0ZsomDNWciTQCGeq4EvPK-cEd1b4EZCBGTRKWQydmDo0m1YrGYEb1YSO4GnHG9sv0Rw9QiaQArnDNTuk7D6pl5cJyDsiHZWR9rcD7-h-BWlv-s_n_9D3BdzpdsCRAdhLOFivNuEV3HK_1st2NYZ9uZDpqsZweHQ8nV2M044EtmZn57Nv4yRZvwFiShgF
linkProvider	Springer Nature
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VgigX3oVtefjAASQC60fs5EgR1Va0KwRl1ZvlV-hKJUGbXX5_x06y0kJ7gGMSR5nY8_R4vgF4hU6qNaoos7JS4wwtlM8KFmK7F7TNaOE4pyY1m1DTaXF2Vn7ZAjrUwqTT7kNKMmnqJNaFfE9RjWZMSBkrwZi8ATcFmqt4iu_rt9k6caDQ_PQIPle8tGF8Ekb_VY7l3-cj_0iSJttzeO8_qL4Pd3tHk3zoOOMBbIX6Idw-6VPpj2CGmqFrKPqWxPPlpO-8Q0ztyc_klKODTpqKLFc2LNzqomnnLZnXJFalt-dkcjQjPSprS1IJdtyQfAzfDz-dfpxkfZOFzGGws8zQITSmxJVURkjHuLXBhLFHSbYFrlxwRV7l0nhBgxnnvqKGl8HERggcow1v-C5s100dngKRkllDFS295SI4aqSQzLPKCoVeWpmP4N0w-9r1COSxEcaFTpFIIXWcLR1nCy81kyN4vX7hVwe-cf3Qg7ic62ERNTvdaBY_dC-EGqOJnDtjlUACjXSmCr70onJOCmelHwEZmEGjlMXUialDs2p1oSJwYzFmI3jS8cb6S4xiRMglUqA2uGaDlM0n9fw8AXlHpKMy0v5m4B3da5D2uv_c-4exL2FncnpyrI-Ppp_34U63G47MwJ_B9nKxCs_hlvu9nLeLF0mGLgF_vRTZ
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagoIoLb-jy9IEDSKTd2I4fR16rVsCqErDqzfIrdKU2qTZZfj9jx1lpoT0gjklsZeyZ8cx47G8QegVOqjVCqkLVYlqAhfKFJCGWewHbDBaO0tKkYhNiPpcnJ-o4n83pxtPuY0pyuNMQUZqa_uDC14OKS35QwpJaEMZ5vBVG-HV0g8WKQTFY_7bYJBEEmKKM5nNJpy1DlPD6L3My_z4r-UfCNNmh2Z3_HMFddDs7oPjdIDH30LXQ3Ee7X3OK_QFawIoxFBp9i-O5c5wr8mDTeHyenHVw3HFb435tw8qtz9pu2eFlg-Nt9e4UHx4tcEZr7XC6mh03Kh-iH7NP3z8cFrn4QuEgCOoLcBSNUcBhYRh3hFobTJh60HArgaPByaquuPGsDGZa-bo0VAUTCyRQiEK8oY_QTtM2YQ9hzok1pSiVt5QFVxrOOPGktkyA96aqCdofOaFdRiaPBTLOdIpQJNdxtnScLXjUhE_Q602HiwGU4-qm7yNrN80imnZ60a5-6qycGqKMijpjBQMCDXemDl55VjvHmbPcTxAeBUOD9sWUimlCu-60FBHQUU7JBD0e5GTzJ1JCpEg5UCC2JGiLlO0vzfI0AXxHBCQVaX8zypHOK0t31Tif_EPbl2j3-ONMfzmaf36Kbg2b5CAL9Bna6Vfr8BzddL_6Zbd6kdTpNzYCHb0
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Incidence%2C+risk+factors+and+mortality+of+tuberculosis+in+Danish+HIV+patients+1995-2007&rft.jtitle=BMC+pulmonary+medicine&rft.au=Taarnh%C3%B8j%2C+Gry+A&rft.au=Engsig%2C+Frederik+N&rft.au=Ravn%2C+Pernille&rft.au=Johansen%2C+Isik+S&rft.date=2011-05-23&rft.issn=1471-2466&rft.eissn=1471-2466&rft.volume=11&rft.spage=26&rft_id=info:doi/10.1186%2F1471-2466-11-26&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2466&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2466&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2466&client=summon